Rigel Pharmaceuticals, Inc.
PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
Last updated:
Abstract:
The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.
Status:
Application
Type:
Utility
Filling date:
2 Mar 2020
Issue date:
27 Aug 2020